Results 281 to 290 of about 325,525 (350)

Navigating the Viral Hepatitis Drug Landscape: New Discoveries and Enduring Challenges. A Narrative Review. [PDF]

Infect Dis Ther
Sun HM, Wang XY, Xu HQ, Gao YH.
europepmc   +1 more source

[Analysis of the Advantages and Clinical Validation of Real-Time Fluorescence Nucleic Acid Isothermal Amplification Detection Technology in Detecting Low Viral Load Samples From HBV-Infected Patients]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Huang Q, Xie R, Lan Y, Xun Z, Ou Q, Liu C.   +5 more
europepmc   +1 more source

Improved Safety of Nucleic Acid Amplification Technology Combined With Serological Tests for Screening Blood Donors: A Systematic Review and Meta-Analysis. [PDF]

Rev Med Virol
Madeira HS, Brustolin AÁ, Almeida MEDS, Ribeiro MVG, Aguera RG, Jorge FA, Ghiraldi LD, Moreira DC, Lonardoni MVC, Bertolini DA, Peder LD, Silva CMD, Lera-Nonose DSSL, Ramos-Milaré ÁCFH, Teixeira JJV.   +14 more
europepmc   +1 more source

Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response. [PDF]

Front Immunol
Kerth HA, Kächele M, Müller N, Singh S, Tulessin M, Sacherl J, Ates Öz E, Su J, Bester R, Miko S, Steiger K, Mogler C, Busch DH, Wettengel JM, Protzer U, Kosinska AD.   +15 more
europepmc   +1 more source

The impact of maternal chronic viral hepatitis infections on pregnancy and neonatal outcomes in in vitro fertilization: a systematic review and meta-analysis. [PDF]

J Ovarian Res
Mao D, Nan W, Lin M, Liu FT, Li J, Qin X, Hu KL, Li R.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection

Nature Reviews Gastroenterology and Hepatology, 2019
Chronic hepatitis B virus (HBV) infection is a serious problem owing to its worldwide distribution and potential adverse sequelae that include cirrhosis and/or hepatocellular carcinoma. Current antiviral therapies have much improved outcomes, but few patients achieve the ultimate goal of hepatitis B surface antigen (HBsAg) loss (functional cure).
Y-F Liaw
exaly   +4 more sources

Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B

Nature Medicine, 2017
Paola Fisicaro, Valeria Barili, Barbara Montanini   +2 more
exaly   +2 more sources

Getting to HBV cure: The promising paths forward

Hepatology, 2022
Chronic HBV infection is a global public health burden estimated to impact nearly 300 million persons worldwide. Despite the advent of potent antiviral agents that effectively suppress viral replication, HBV cure remains difficult to achieve because of ...
S. Fung, H. Choi, A. Gehring, H. Janssen
semanticscholar   +1 more source

HBV vaccination and HBV infection induces HBV-specific natural killer cell memory

Gut, 2020
ObjectiveVaccination against hepatitis B virus (HBV) confers protection from subsequent infection through immunological memory that is traditionally considered the domain of the adaptive immune system. This view has been challenged following the identification of antigen-specific memory natural killer cells (mNKs) in mice and non-human primates.
Ratna S Wijaya, Scott A Read, Naomi R Truong, Shuanglin Han, Dishen Chen, Haleh Shahidipour, Nicole L Fewings, Stephen Schibeci, Mahmoud K Azardaryany, Grant P Parnell, David Booth, David van der Poorten, Rita Lin, Jacob George, Mark W Douglas, Golo Ahlenstiel   +15 more
openaire   +3 more sources